All lobbying filings

AVIVA STRATEGIES (FKA MGB CONSULTING)

AVIVA STRATEGIES (FKA MGB CONSULTING) filed a Q1 report for ENDEAVOR BIOMEDICINES on May 6, 2025, reporting $8,500 in lobbying income.

Lobbying for ENDEAVOR BIOMEDICINES · Biotechnology & therapeutics

All filings by AVIVA STRATEGIES (FKA MGB CONSULTING) · Everything ENDEAVOR BIOMEDICINES has reported

Filing · LD-2 quarterly report Q1 report

Reporting period

1st Quarter 2025

Jan 1 - Mar 31 · Posted May 6, 2025

Income

$8,500

What the client paid this registrant for the period.

Client based in

California

Official filing document

Government bodies contacted 2

HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

RESULT Act FDA Modernization

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.